Editorial comment.
作者信息
Madersbacher Stephan
出版信息
Urology. 2011 Sep;78(3):646-7. doi: 10.1016/j.urology.2011.03.064.
Abstract
摘要
相似文献
1
Editorial comment.
Urology. 2011 Sep;78(3):646-7. doi: 10.1016/j.urology.2011.03.064.
2
Dutasteride and prostate cancer.度他雄胺与前列腺癌
N Engl J Med. 2010 Aug 19;363(8):794; author reply 794-6. doi: 10.1056/NEJMc1005498.
3
Dutasteride and prostate cancer.度他雄胺与前列腺癌
N Engl J Med. 2010 Aug 19;363(8):793; author reply 794-5. doi: 10.1056/NEJMc1005498.
4
Dutasteride and prostate cancer.度他雄胺与前列腺癌
N Engl J Med. 2010 Aug 19;363(8):794; author reply 795-6. doi: 10.1056/NEJMc1005498.
5
Dutasteride and prostate cancer.度他雄胺与前列腺癌
N Engl J Med. 2010 Aug 19;363(8):793-4; author reply 794-5. doi: 10.1056/NEJMc1005498.
6
[Combined dutasteride and tamsulosin].度他雄胺与坦索罗辛联用
Urologia. 2011 Oct-Dec;78(4):317-9. doi: 10.5301/RU.2011.8793.
7
Editorial comment.编辑评论。
Urology. 2014 Feb;83(2):421. doi: 10.1016/j.urology.2013.09.039. Epub 2013 Dec 12.
8
9
Dutasteride improves outcomes of benign prostatic hyperplasia when evaluated for prostate cancer risk reduction: secondary analysis of the REduction by DUtasteride of prostate Cancer Events (REDUCE) trial.度他雄胺可降低前列腺癌风险，从而改善良性前列腺增生的预后：度他雄胺减少前列腺癌事件（REDUCE）试验的二次分析。
Urology. 2011 Sep;78(3):641-6. doi: 10.1016/j.urology.2011.03.063. Epub 2011 Jul 20.
10
Evolving role of 5-alpha reductase inhibitors in chemoprevention.5-α还原酶抑制剂在化学预防中的作用演变
Nat Rev Clin Oncol. 2010 Sep;7(9):487-8. doi: 10.1038/nrclinonc.2010.114.
Zotero 插件